Michael Benkowitz's most recent trade in United Therapeutics Corp was a trade of 14,625 Common Stock done at an average price of $135.4 . Disclosure was reported to the exchange on Sept. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 02 Sep 2025 | 14,625 | 14,625 (0%) | 0% | 135.4 | 1,980,518 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2025 | 14,625 | 172,875 | - | - | Stock Options | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 419.63 per share. | 02 Sep 2025 | 11,375 | 3,250 (0%) | 0% | 419.6 | 4,773,291 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 02 Sep 2025 | 7,875 | 7,875 (0%) | 0% | 146.0 | 1,149,986 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2025 | 7,875 | 55,125 | - | - | Stock Options | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 419.63 per share. | 02 Sep 2025 | 6,125 | 0 (0%) | 0% | 419.6 | 2,570,234 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 409.97 per share. | 02 Sep 2025 | 1,144 | 800 (0%) | 0% | 410.0 | 469,005 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 407.26 per share. | 02 Sep 2025 | 888 | 6,987 (0%) | 0% | 407.3 | 361,651 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 408.97 per share. | 02 Sep 2025 | 700 | 1,944 (0%) | 0% | 409.0 | 286,280 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 407.34 per share. | 02 Sep 2025 | 500 | 2,644 (0%) | 0% | 407.3 | 203,669 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 417.45 per share. | 02 Sep 2025 | 367 | 6,220 (0%) | 0% | 417.4 | 153,204 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 418.03 per share. | 02 Sep 2025 | 328 | 72 (0%) | 0% | 418.0 | 137,114 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 408.28 per share. | 02 Sep 2025 | 300 | 6,687 (0%) | 0% | 408.3 | 122,483 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 416.30 per share. | 02 Sep 2025 | 200 | 400 (0%) | 0% | 416.3 | 83,261 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 412.70 per share. | 02 Sep 2025 | 168 | 632 (0%) | 0% | 412.7 | 69,333 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 405.59 per share. | 02 Sep 2025 | 106 | 3,144 (0%) | 0% | 405.6 | 42,993 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 410.35 per share. | 02 Sep 2025 | 100 | 6,587 (0%) | 0% | 410.4 | 41,035 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 419.61 per share. | 02 Sep 2025 | 95 | 6,125 (0%) | 0% | 419.6 | 39,863 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 419.35 per share. | 02 Sep 2025 | 72 | 0 (0%) | 0% | 419.3 | 30,193 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 413.38 per share. | 02 Sep 2025 | 32 | 600 (0%) | 0% | 413.4 | 13,228 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.00 per share. | 10 Mar 2025 | 2,000 | 2,000 (0%) | 0% | 111 | 222,000 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,000 | 0 | - | - | Stock Options | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 320.57 per share. | 10 Mar 2025 | 533 | 758 (0%) | 0% | 320.6 | 170,864 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 321.61 per share. | 10 Mar 2025 | 358 | 400 (0%) | 0% | 321.6 | 115,138 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 319.35 per share. | 10 Mar 2025 | 316 | 1,291 (0%) | 0% | 319.4 | 100,915 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 322.86 per share. | 10 Mar 2025 | 300 | 100 (0%) | 0% | 322.9 | 96,857 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 317.11 per share. | 10 Mar 2025 | 200 | 1,607 (0%) | 0% | 317.1 | 63,422 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 313.93 per share. | 10 Mar 2025 | 193 | 1,807 (0%) | 0% | 313.9 | 60,588 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 323.99 per share. | 10 Mar 2025 | 100 | 0 (0%) | 0% | 324.0 | 32,399 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.00 per share. | 03 Mar 2025 | 7,179 | 7,179 (0%) | 0% | 111 | 796,869 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 7,179 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 2,500 | 2,000 | - | - | Stock Options | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.00 per share. | 03 Mar 2025 | 2,500 | 2,500 (0%) | 0% | 111 | 277,500 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 309.69 per share. | 03 Mar 2025 | 2,010 | 3,869 (0%) | 0% | 309.7 | 622,480 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 308.66 per share. | 03 Mar 2025 | 1,300 | 5,879 (0%) | 0% | 308.7 | 401,252 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 313.98 per share. | 03 Mar 2025 | 1,026 | 1,200 (0%) | 0% | 314.0 | 322,144 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 313.33 per share. | 03 Mar 2025 | 843 | 2,226 (0%) | 0% | 313.3 | 264,139 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 309.82 per share. | 03 Mar 2025 | 800 | 1,300 (0%) | 0% | 309.8 | 247,858 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 313.93 per share. | 03 Mar 2025 | 600 | 400 (0%) | 0% | 313.9 | 188,357 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 316.97 per share. | 03 Mar 2025 | 578 | 500 (0%) | 0% | 317.0 | 183,206 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 310.54 per share. | 03 Mar 2025 | 550 | 3,319 (0%) | 0% | 310.5 | 170,795 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 308.99 per share. | 03 Mar 2025 | 400 | 2,100 (0%) | 0% | 309.0 | 123,596 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 317.93 per share. | 03 Mar 2025 | 363 | 137 (0%) | 0% | 317.9 | 115,409 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 311.01 per share. | 03 Mar 2025 | 300 | 1,000 (0%) | 0% | 311.0 | 93,304 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 317.41 per share. | 03 Mar 2025 | 300 | 100 (0%) | 0% | 317.4 | 95,223 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 311.74 per share. | 03 Mar 2025 | 250 | 3,069 (0%) | 0% | 311.7 | 77,934 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 318.82 per share. | 03 Mar 2025 | 137 | 0 (0%) | 0% | 318.8 | 43,678 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 315.49 per share. | 03 Mar 2025 | 122 | 1,078 (0%) | 0% | 315.5 | 38,490 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 318.70 per share. | 03 Mar 2025 | 100 | 0 (0%) | 0% | 318.7 | 31,870 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.00 per share. | 24 Feb 2025 | 7,500 | 7,500 (0%) | 0% | 111 | 832,500 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 7,500 | 7,179 | - | - | Stock Option | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.00 per share. | 24 Feb 2025 | 2,500 | 2,500 (0%) | 0% | 111 | 277,500 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 2,500 | 4,500 | - | - | Stock Options | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 361.87 per share. | 24 Feb 2025 | 2,100 | 803 (0%) | 0% | 361.9 | 759,918 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 359.88 per share. | 24 Feb 2025 | 1,598 | 4,423 (0%) | 0% | 359.9 | 575,089 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 360.72 per share. | 24 Feb 2025 | 1,520 | 2,903 (0%) | 0% | 360.7 | 548,299 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 358.67 per share. | 24 Feb 2025 | 1,479 | 6,021 (0%) | 0% | 358.7 | 530,475 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 361.13 per share. | 24 Feb 2025 | 841 | 696 (0%) | 0% | 361.1 | 303,710 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 358.85 per share. | 24 Feb 2025 | 763 | 1,737 (0%) | 0% | 358.9 | 273,805 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 362.29 per share. | 24 Feb 2025 | 496 | 200 (0%) | 0% | 362.3 | 179,696 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 362.79 per share. | 24 Feb 2025 | 403 | 400 (0%) | 0% | 362.8 | 146,205 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 364.27 per share. | 24 Feb 2025 | 400 | 0 (0%) | 0% | 364.3 | 145,707 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 359.76 per share. | 24 Feb 2025 | 200 | 1,537 (0%) | 0% | 359.8 | 71,953 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 363.48 per share. | 24 Feb 2025 | 200 | 0 (0%) | 0% | 363.5 | 72,696 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.00 per share. | 18 Feb 2025 | 7,500 | 7,500 (0%) | 0% | 111 | 832,500 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 7,500 | 14,679 | - | - | Stock Option | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,500 | 7,000 | - | - | Stock Options | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.00 per share. | 18 Feb 2025 | 2,500 | 2,500 (0%) | 0% | 111 | 277,500 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 371.47 per share. | 18 Feb 2025 | 2,351 | 1,949 (0%) | 0% | 371.5 | 873,318 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 372.62 per share. | 18 Feb 2025 | 1,549 | 400 (0%) | 0% | 372.6 | 577,196 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 369.65 per share. | 18 Feb 2025 | 1,432 | 5,368 (0%) | 0% | 369.7 | 529,343 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 370.70 per share. | 18 Feb 2025 | 1,068 | 4,300 (0%) | 0% | 370.7 | 395,911 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 370.85 per share. | 18 Feb 2025 | 601 | 1,199 (0%) | 0% | 370.9 | 222,883 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 371.67 per share. | 18 Feb 2025 | 600 | 599 (0%) | 0% | 371.7 | 223,003 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 368.32 per share. | 18 Feb 2025 | 600 | 6,800 (0%) | 0% | 368.3 | 220,994 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 369.43 per share. | 18 Feb 2025 | 500 | 1,800 (0%) | 0% | 369.4 | 184,713 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 372.82 per share. | 18 Feb 2025 | 499 | 100 (0%) | 0% | 372.8 | 186,036 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 373.67 per share. | 18 Feb 2025 | 400 | 0 (0%) | 0% | 373.7 | 149,469 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 367.97 per share. | 18 Feb 2025 | 200 | 2,300 (0%) | 0% | 368.0 | 73,594 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 374.18 per share. | 18 Feb 2025 | 100 | 0 (0%) | 0% | 374.2 | 37,418 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 366.19 per share. | 18 Feb 2025 | 100 | 7,400 (0%) | 0% | 366.2 | 36,619 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.00 per share. | 10 Feb 2025 | 7,500 | 7,500 (0%) | 0% | 111 | 832,500 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 7,500 | 22,179 | - | - | Stock Options | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 347.98 per share. | 10 Feb 2025 | 3,697 | 2,461 (0%) | 0% | 348.0 | 1,286,481 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 2,500 | 9,500 | - | - | Stock Option | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.00 per share. | 10 Feb 2025 | 2,500 | 2,500 (0%) | 0% | 111 | 277,500 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 349.10 per share. | 10 Feb 2025 | 1,696 | 765 (0%) | 0% | 349.1 | 592,071 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 348.12 per share. | 10 Feb 2025 | 1,200 | 800 (0%) | 0% | 348.1 | 417,747 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 345.69 per share. | 10 Feb 2025 | 1,142 | 6,358 (0%) | 0% | 345.7 | 394,778 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 349.90 per share. | 10 Feb 2025 | 720 | 45 (0%) | 0% | 349.9 | 251,926 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 349.30 per share. | 10 Feb 2025 | 700 | 100 (0%) | 0% | 349.3 | 244,507 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 345.90 per share. | 10 Feb 2025 | 500 | 2,000 (0%) | 0% | 345.9 | 172,948 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 346.53 per share. | 10 Feb 2025 | 200 | 6,158 (0%) | 0% | 346.5 | 69,306 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 350.18 per share. | 10 Feb 2025 | 100 | 0 (0%) | 0% | 350.2 | 35,018 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 352.42 per share. | 10 Feb 2025 | 45 | 0 (0%) | 0% | 352.4 | 15,859 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.00 per share. | 03 Feb 2025 | 7,500 | 7,500 (0%) | 0% | 111 | 832,500 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 7,500 | 29,679 | - | - | Stock Options | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 2,500 | 12,000 | - | - | Stock Option | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.00 per share. | 03 Feb 2025 | 2,500 | 2,500 (0%) | 0% | 111 | 277,500 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 356.81 per share. | 03 Feb 2025 | 1,600 | 200 (0%) | 0% | 356.8 | 570,890 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 355.63 per share. | 03 Feb 2025 | 1,204 | 1,800 (0%) | 0% | 355.6 | 428,174 | Common Stock |